Control Bionics Limited (CBL.AX)
AUD 0.06
(-1.69%)
AUD 0.06
(-1.69%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -5.92 Million AUD | -5.52% |
| 2023 | -5.61 Million AUD | 7.77% |
| 2022 | -6.09 Million AUD | -73.17% |
| 2021 | -3.51 Million AUD | -192.17% |
| 2020 | -1.2 Million AUD | 41.3% |
| 2019 | -2.05 Million AUD | -93.81% |
| 2018 | -1.05 Million AUD | -101.85% |
| 2017 | 57.06 Million NZD | 2.24% |
| 2016 | 55.81 Million NZD | 0.0% |
| 2015 | - NZD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | -1.78 Million AUD | 0.0% |
| 2024 Q3 | -1.78 Million AUD | 33.93% |
| 2024 FY | -6.86 Million AUD | -22.2% |
| 2024 Q1 | -1.12 Million AUD | 62.65% |
| 2024 Q2 | -2.7 Million AUD | -140.6% |
| 2023 Q1 | -1.57 Million AUD | 52.64% |
| 2023 FY | -5.61 Million AUD | 7.77% |
| 2023 Q2 | -3.06 Million AUD | -94.88% |
| 2023 Q4 | -3 Million AUD | -150.32% |
| 2023 Q3 | -1.2 Million AUD | 60.82% |
| 2022 FY | -6.09 Million AUD | -73.17% |
| 2022 Q4 | -3.32 Million AUD | 0.0% |
| 2021 FY | -3.51 Million AUD | -192.17% |
| 2020 FY | -1.2 Million AUD | 41.3% |
| 2019 FY | -2.05 Million AUD | -93.81% |
| 2018 FY | -1.05 Million AUD | -101.85% |
| 2017 FY | 57.06 Million NZD | 2.24% |
| 2016 FY | 55.81 Million NZD | 0.0% |
| 2016 Q4 | 14.26 Million NZD | 0.0% |
| 2016 Q3 | 14.26 Million NZD | 0.0% |
| 2016 Q2 | 14.26 Million NZD | 2.24% |
| 2016 Q1 | 13.95 Million NZD | 0.0% |
| 2015 Q2 | 13.95 Million NZD | 0.0% |
| 2015 Q4 | 13.95 Million NZD | 0.0% |
| 2015 Q3 | 13.95 Million NZD | 0.0% |
| 2015 FY | - NZD | 0.0% |
| 2015 Q1 | - NZD | 0.0% |
| 2014 Q2 | - NZD | 0.0% |
| 2014 Q4 | - NZD | 0.0% |
| 2014 Q3 | - NZD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| 4DMedical Limited | -27.96 Million AUD | 78.799% |
| Adherium Limited | -11.98 Million AUD | 50.529% |
| Aroa Biosurgery Limited | -9.78 Million AUD | 39.421% |
| Atomo Diagnostics Limited | -4.36 Million AUD | -35.946% |
| Anteris Technologies Ltd | -66.63 Million AUD | 91.102% |
| CardieX Limited | -4.63 Million AUD | -27.959% |
| Compumedics Limited | -269 Thousand AUD | -2104.188% |
| Cochlear Limited | 521.5 Million AUD | 101.137% |
| CleanSpace Holdings Limited | -4.81 Million AUD | -23.168% |
| Cyclopharm Limited | -9.22 Million AUD | 35.724% |
| EMVision Medical Devices Ltd | -1.61 Million AUD | -267.272% |
| Nova Eye Medical Limited | -3.79 Million AUD | -56.157% |
| HeraMED Limited | -6.42 Million AUD | 7.759% |
| Imricor Medical Systems, Inc. | -17.57 Million AUD | 66.264% |
| ImpediMed Limited | -19.03 Million AUD | 68.852% |
| InhaleRx Limited | -1.38 Million AUD | -327.647% |
| LBT Innovations Limited | -4.74 Million AUD | -25.09% |
| Micro-X Limited | -13.02 Million AUD | 54.485% |
| Neurotech International Limited | -5.58 Million AUD | -6.168% |
| OncoSil Medical Limited | -11.98 Million AUD | 50.524% |
| PolyNovo Limited | 1.16 Million AUD | 609.825% |
| Respiri Limited | -7 Million AUD | 15.299% |
| SomnoMed Limited | -3.84 Million AUD | -54.356% |
| Universal Biosensors, Inc. | -16.68 Million AUD | 64.454% |
| Uscom Limited | -2.4 Million AUD | -146.606% |
| Visioneering Technologies, Inc. | -5.85 Million AUD | -1.283% |